Results 111 to 120 of about 18,708 (185)

Reversal of left ventricular hypertrophy with sacubitril/valsartan vs. standard antihypertensive agents in hypertension: a systematic review and network meta-analysis. [PDF]

Front Cardiovasc Med
Tang W, Qin W, Su Y, Yang F, He G.
europepmc   +1 more source

Clinical Outcomes Associated With In-Hospital Versus Delayed Outpatient Initiation of Sacubitril/Valsartan in Patients With Heart Failure With Reduced Ejection Fraction. [PDF]

Cureus
Oletu H, Oladimeji A, Muoghalu N, Opoku KA, Osueni A, Arifayan SO, Opara IA, Okwuokei E, Peteranaba SF.   +8 more
europepmc   +1 more source

The potential effect and pathway of valsartan: genome-wide and phenome-wide association study from UK Biobank data. [PDF]

Pharmacogenet Genomics
Zeng S, Li Y, Zhang Y, Lu Y, Ruan L, Zhang C, Zhang J, Chen B, Li T.   +8 more
europepmc   +1 more source

Dual Empagliflozin and Sacubitril/Valsartan Therapy Improves Ex Vivo Cardiac Function in a Rat Model of Heart Failure. [PDF]

Biomedicines
Murić M, Srejović I, Ravić M, Joksimović Jović J, Sretenović J, Nikolić M, Lazarević N, Andjić M, Kočović A, Bolevich S, Jakovljević V, Novaković J.   +11 more
europepmc   +1 more source

Tacrolimus Induced Hypertension and Vascular Remodeling Includes Mechanisms of Cellular Senescence-The Protective Effect of Valsartan. [PDF]

Acta Physiol (Oxf)
Fei L, Wang X, Kong L, Cui T, Khedkar PH, Xiang Y, Zhao D, Fang J, Liang Y, Zhang Y, Xu N, Qiu X, Zhao L, Zhang G, Lei Y, Tang C, Ma K, Lu L, Wei J, Lai EY, Persson PB, Patzak A, Zheng Z, Jiang S.   +23 more
europepmc   +1 more source

Angiotensin-Neprilysin Inhibition and Renal Outcome in Men and Women With Heart Failure. [PDF]

J Am Heart Assoc
Kim W, Yoon M, Kook W, Park JJ, Greenberg B.   +4 more
europepmc   +1 more source

Effects of sacubitril/valsartan combined with ivabradine in treating cardiorenal syndrome. [PDF]

Am J Transl Res
Li G, Liu H, Zhou S, Xiong W.
europepmc   +1 more source

Expert Opinion on Optimising Guideline-Directed Medical Therapy and Expanding the Role of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) for Heart Failure Management in India. [PDF]

Cureus
Pandey BP, Ray S, Kumar S, Guha S, Desai BN, Shah MK, Kudva S, Chopra VK, Agarwal R, Rastogi V, Ponde CK, Sharma RK, Pawar D, Chavan G, Kolapkar V.   +14 more
europepmc   +1 more source

Effect of sacubitril/valsartan and SGLT2 inhibitors on arrhythmia burden in ICD patients. [PDF]

BMC Cardiovasc Disord
Öztürk F, Yaman M.
europepmc   +1 more source

Efficacy and Safety of Sacubitril/Valsartan After Switching From Azilsartan in Essential Hypertensive Patients: Based on Home Blood Pressure Monitoring. [PDF]

J Clin Hypertens (Greenwich)
Iwashima Y, Sugiura M, Horio T, Yamamoto K, Takahashi N.   +4 more
europepmc   +1 more source